WELLINGTON MANAGEMENT GROUP LLP - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$462,157
-49.2%
101,573
-21.4%
0.00%
Q2 2023$909,568
-3.6%
129,200
-16.4%
0.00%
Q1 2023$943,909
-65.0%
154,486
-63.4%
0.00%
-100.0%
Q4 2022$2,694,088
-82.8%
421,610
-74.3%
0.00%
-66.7%
Q3 2022$15,706,000
+6.6%
1,639,535
+22.9%
0.00%0.0%
Q2 2022$14,728,000
-92.2%
1,334,062
-88.2%
0.00%
-90.6%
Q1 2022$187,957,000
+2.7%
11,288,726
+17.8%
0.03%
+10.3%
Q4 2021$182,959,000
-16.6%
9,584,082
+7.7%
0.03%
-21.6%
Q3 2021$219,462,000
+16.3%
8,899,530
+22.7%
0.04%
+19.4%
Q2 2021$188,677,000
-17.8%
7,251,243
+0.0%
0.03%
-22.5%
Q1 2021$229,460,000
-11.9%
7,247,657
+29.1%
0.04%
-16.7%
Q4 2020$260,394,000
+1122.0%
5,611,932
+767.0%
0.05%
+1100.0%
Q3 2020$21,309,000
+19.5%
647,310
-0.3%
0.00%0.0%
Q2 2020$17,827,000
-66.4%
649,432
-63.4%
0.00%
-71.4%
Q1 2020$53,116,000
-20.2%
1,774,372
-26.2%
0.01%0.0%
Q4 2019$66,535,000
+218.3%
2,403,704
+109.3%
0.01%
+180.0%
Q3 2019$20,905,000
+120.1%
1,148,635
+196.5%
0.01%
+150.0%
Q2 2019$9,498,000
+1074.0%
387,377
+512.6%
0.00%
Q2 2018$809,000
-33.3%
63,237
-11.9%
0.00%
Q1 2018$1,213,00071,7850.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,876,600$127,618,00011.48%
Fairmount Funds Management LLC 596,890$19,650,0008.32%
Ghost Tree Capital, LLC 575,000$18,929,0005.47%
Perceptive Advisors 10,085,632$332,019,0004.85%
Avoro Capital Advisors LLC 9,536,039$313,926,0004.46%
FRAZIER MANAGEMENT LLC 1,312,999$43,224,0003.88%
ACUTA CAPITAL PARTNERS, LLC 315,000$10,370,0002.82%
Orbimed Advisors 6,645,100$218,757,0002.75%
QVT Financial LP 572,971$18,862,0002.30%
Prosight Management, LP 120,606$3,970,0001.89%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders